|
Vector Mediated Gene Delivery & Manipulation |
|
Genome Editing & Cell Line Generation |
|
|
|
Comprehensive viral-based & non-viral-based vectors in specific cells, |
Targeted genome editing platform for knockout, knock-in at cell types of |
|
|
tissue, organ or systemic gene delivery & manipulation in vitro & in vivo |
interest |
|
|
• AAVs-based (various serotypes) on efficient & less tox manipulation & |
• Reporter-based assay systems using endogenous or external promoters |
|
|
delivery |
• Modification of endogenous genes (e.g. polymorphisms, site-directed |
|
|
• Lentiviral-based mediated inducible cell lines for xenograft models |
mutations) |
|
|
• Retroviral-based gene manipulation in cell lines |
• Biologic function of any gene or pathway |
|
|
• siRNA & shRNA-based gene manipulation |
• Physiologically relevant genes, Boosting or retaining
|
|
|
• siRNA and CRISPR sgRNA library screening and target id |
• CRISPR/cas9 technology for isogenic cell line generation |
|
|
|
Phenotypic Characterization |
|
|
Transgenic technology for the generation of animal disease models & |
• In vitro functional readouts, gene expression profiling, target MOA, & |
|
|
target engagement for proof-of-concept |
pathway analysis |
|
|
• Conventional knockout, knockdown, & knock-in mice |
• In vivo phenotypic characterizations in various disease models |
|
|
• Conditional, brain, other organ, or cell type specific knockout mice |
(Metabolic disease, Oncology, CNS, & inflammation) |
|
|
• Region or cell type specific inducible/reversible transgenic mice |
• Biomarker discovery, IHC, in situ protein expression with bioinformatics supports |
|
|
• BAC/YAC transgenic mice for humanized animal model |
• Bioinformatics supports & data analysis |
|
|